We are live on ! Find out more
AHL

Abel Hall LLC Portfolio holdings

AUM $579M
1-Year Est. Return 54.21%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+54.21%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$31.3M
Cap. Flow
+$15.2M
Cap. Flow %
6.13%
Top 10 Hldgs %
42.72%
Holding
358
New
69
Increased
110
Reduced
101
Closed
34

Top Buys

Rank Stock Value
1
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$2.25M
2
DFSV
Dimensional US Small Cap Value ETF
DFSV
+$851K
3
OKE icon
Oneok
OKE
+$833K
4
NEA icon
Nuveen AMT-Free Quality Municipal Income Fund
NEA
+$770K
5
DUHP icon
Dimensional US High Profitability ETF
DUHP
+$633K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$1M
2
TSM icon
TSMC
TSM
+$519K
3
DINO icon
HF Sinclair
DINO
+$451K
4
CAT icon
Caterpillar
CAT
+$429K
5
PG icon
Procter & Gamble
PG
+$428K

Sector Composition

Rank Sector Weight
1 Technology 11.1%
2 Financials 6.28%
3 Energy 5.71%
4 Healthcare 4.27%
5 Real Estate 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BORR
301
Borr Drilling
BORR
$1.18B
$42.6K 0.02%
+15,852
New +$39.4K
OVID icon
302
Ovid Therapeutics
OVID
$427M
$42.1K 0.02%
32,348
– –
REI icon
303
Ring Energy
REI
$307M
$38.6K 0.02%
35,380
– –
SES icon
304
SES AI
SES
$195M
$38.5K 0.02%
23,063
– –
HPP
305
Hudson Pacific Properties
HPP
$788M
$36.1K 0.01%
1,867
+427
+30% +$8.05K
SERA icon
306
Sera Prognostics
SERA
$81.5M
$33.8K 0.01%
11,037
– –
MRVI icon
307
Maravai LifeSciences
MRVI
$984M
$32.9K 0.01%
+11,480
New +$29.3K
ESPR
308
DELISTED
Esperion Therapeutics
ESPR
$32.2K 0.01%
12,142
-170
-1% -$329
TLYS icon
309
Tilly's
TLYS
$114M
$28.7K 0.01%
13,930
-175
-1% -$303
AKBA icon
310
Akebia Therapeutics
AKBA
$338M
$28.7K 0.01%
10,500
-118
-1% -$393
OCGN icon
311
Ocugen
OCGN
$403M
$24.1K 0.01%
14,778
-140
-0.9% -$155
URG
312
Ur-Energy
URG
$481M
$23.2K 0.01%
12,981
– –
ALXO icon
313
ALX Oncology
ALXO
$264M
$23.1K 0.01%
12,598
-2,611
-17% -$2.26K
CCCC icon
314
C4 Therapeutics
CCCC
$393M
$22.5K 0.01%
10,140
-85
-0.8% -$204
CHGG icon
315
Chegg
CHGG
$119M
$22.3K 0.01%
14,794
– –
ARAY icon
316
Accuray
ARAY
$27.8M
$16.7K 0.01%
+10,023
New +$14.8K
BOLD
317
Boundless Bio
BOLD
$55.7M
$15.9K 0.01%
12,925
-1,474
-10% -$1.7K
LAB icon
318
Standard BioTools
LAB
$344M
$14.8K 0.01%
11,370
+185
+2% +$242
PACB icon
319
Pacific Biosciences
PACB
$441M
$14.2K 0.01%
11,088
-895
-7% -$1.21K
HBIO icon
320
Harvard Bioscience
HBIO
$27.5M
$14.1K 0.01%
3,221
-512
-14% -$2.43K
TVGN icon
321
Tevogen Bio Holdings
TVGN
$25.3M
$10.3K ﹤0.01%
263
-20
-7% -$984
MYO icon
322
Myomo
MYO
$36.8M
$10.1K ﹤0.01%
+11,285
New +$16.4K
ILLR
323
Triller Group Inc
ILLR
$19.5M
$8.7K ﹤0.01%
+1,048
New +$7.09K
UTF.RT
324
DELISTED
Cohen & Steers Infrastructure Fund Rights exp Oct 16 2025
UTF.RT
$1.72K ﹤0.01%
+22,000
New +$1.66K
ABT icon
325
Abbott
ABT
$190B
– –
-2,237
Closed -$304K
11 12
13
14 15

Similar funds

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
EIP
Ellis Investment Partners Berwyn, Pennsylvania $576M AUM 16.04% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return

Abel Hall LLC's Q3 2025 Portfolio in Review

As of Q3 2025, Abel Hall LLC held 358 positions worth $248M, up 14% from $216M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Abel Hall LLC deployed $15.2M of net new capital in Q3 2025, opening 69 new positions and adding to 110 existing holdings. Its largest new stake was Oneok: 10,882 shares worth $794K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Caterpillar, an estimated $429K trimmed.

  • Abel Hall LLC's largest Q3 2025 buy was Oneok: 10,882 shares worth $794K.
  • Abel Hall LLC added most to Dimensional US Core Equity 2 ETF in Q3 2025, an estimated $2.25M increase.
  • Abel Hall LLC's biggest Q3 2025 reduction was Caterpillar, cutting an estimated $429K.
  • Abel Hall LLC fully exited Delek US in Q3 2025, selling an estimated $1M.
  • Abel Hall LLC's ten largest holdings make up 43% of its $248M portfolio in Q3 2025.
  • Abel Hall LLC opened 69 new positions and closed 34 in Q3 2025.
  • Abel Hall LLC's portfolio value rose 14% quarter-over-quarter to $248M.

Based on Abel Hall LLC's 13F filing for Q3 2025, filed 17 Nov 2025.